VS

Vivek Singh

Active Director Director DIN 09401156
DIN 09401156 First appointment Nov 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Vivek Singh

Data last updated:

Vivek Singh is a Director at Vmvs Nexgen Pharmarise India Private Limited (since 2021). The company operates in Chemicals. Vmvs Nexgen Pharmarise India Private Limited reported revenue of ₹37.7 Lakh (FY 2025).

DIN 09401156
Primary Designation Director
Industry Chemicals
First Appointment 16 Nov 2021
Oldest Company Age 4 yrs
Largest company Vmvs Nexgen Pharmarise India Private Limited · ₹37.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Nov 20212021₹37.7 Lakh (FY 2025)Active

Board colleagues of Vivek Singh

Directorship timeline

Open interactive timeline →
Vmvs Nexgen Pharmarise India Private Limited
Premium access

Shareholding and investment profile for Vivek Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Singh

Vivek Singh currently holds 1 directorship: Vmvs Nexgen Pharmarise India Private Limited (Director, since 16 Nov 2021, revenue ₹37.7 Lakh (FY 2025)).

Vivek Singh was first appointed on 16 Nov 2021 as Director at Vmvs Nexgen Pharmarise India Private Limited.

The current boards of Vivek Singh's companies include Akanksha Singh Gaur (Vmvs Nexgen Pharmarise India Private Limited), Deepti Srivastava (Vmvs Nexgen Pharmarise India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available